P3 Health Partners Inc.
PIII · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $345,253 | $355,788 | $373,225 | $370,686 |
| % Growth | -3% | -4.7% | 0.7% | – |
| Cost of Goods Sold | $369,789 | $0 | $379,005 | $0 |
| Gross Profit | -$24,536 | $355,788 | -$5,780 | $370,686 |
| % Margin | -7.1% | 100% | -1.5% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $22,139 | $23,295 | $24,999 | $31,366 |
| SG&A Expenses | $22,390 | $23,446 | $25,180 | $31,827 |
| Sales & Mktg Exp. | $251 | $151 | $181 | $461 |
| Other Operating Expenses | -$2,703 | $366,466 | $7,128 | $477,362 |
| Operating Expenses | $19,687 | $389,912 | $32,308 | $509,189 |
| Operating Income | -$44,223 | -$34,124 | -$38,088 | -$138,503 |
| % Margin | -12.8% | -9.6% | -10.2% | -37.4% |
| Other Income/Exp. Net | -$25,227 | -$7,560 | -$5,085 | $14,307 |
| Pre-Tax Income | -$69,450 | -$41,684 | -$43,173 | -$124,196 |
| Tax Expense | $11 | $1,981 | $1,073 | $4,952 |
| Net Income | -$31,587 | -$20,362 | -$20,480 | -$58,617 |
| % Margin | -9.1% | -5.7% | -5.5% | -15.8% |
| EPS | -9.67 | -6.23 | -6.28 | -18.02 |
| % Growth | -55.2% | 0.8% | 65.1% | – |
| EPS Diluted | -9.67 | -6.23 | -6.28 | -20.82 |
| Weighted Avg Shares Out | 3,268 | 3,267 | 3,260 | 3,253 |
| Weighted Avg Shares Out Dil | 3,268 | 3,267 | 3,260 | 3,253 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $322 | $0 |
| Interest Expense | $20,527 | $10,145 | $8,725 | $6,834 |
| Depreciation & Amortization | $21,033 | $21,083 | $21,052 | $21,153 |
| EBITDA | -$27,890 | -$10,456 | -$13,396 | -$96,209 |
| % Margin | -8.1% | -2.9% | -3.6% | -26% |